-
Email -
Telephone
Vydura
Wafers
- Dissolve under the tongue
- Effective within 2 hours
- Fewer side effects
Price Checker
£49.99
Vydura Medical Information
VYDURA contains the active ingredient rimegepant, that stops the activity of a substance in the body called calcitonin gene-related peptide (CGRP). People with migraine may have increased levels of CGRP. Rimegepant attaches to the receptor for CGRP, reducing the ability of CGRP to also attach to the receptor. This reduces the activity of CGRP and has two effects:
1) it can stop an active migraine attack, and
2) it can decrease the number of migraine attacks that occur when taken preventively.
VYDURA is used to treat and prevent migraine attacks in adults.
For prevention of migraine, the recommended dose is one oral lyophilisate (75 mg rimegepant) every other day.
For treatment of a migraine attack once it has started, the recommended dose is one oral lyophilisate (75 mg rimegepant) as needed, not more than once daily.
The maximum daily dose is one oral lyophilisate (75 mg rimegepant) per day.
The oral lyophilisate can be taken with or without food or water.
Instructions:
Use dry hands when opening.
Peel back the foil covering of one blister and gently remove the oral lyophilisate.
Do not push the oral lyophilisate through the foil.
As soon as the blister is opened, remove the oral lyophilisate and place it on or under the tongue, where it will dissolve.
No drink or water is needed.
Do not store the oral lyophilisate outside the blister for future use.
Do not take Vydura if you are allergic to rimegepant or any of the other ingredients of this medicine.
A common side effect (up to 1 in 10 people) is nausea.
See other migraine medicines available.
